Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus

Women with systemic lupus erythematosus (SLE) have increased risk for coronary heart disease (CHD) which is underestimated by the Framingham risk score (FRS). We hypothesized that new risk scores that include inflammation or vascular age in the risk calculation would better identify women with SLE a...

Full description

Saved in:
Bibliographic Details
Published in:Lupus 2011-12, Vol.20 (14), p.1526-1534
Main Authors: Kawai, VK, Solus, JF, Oeser, A, Rho, YH, Raggi, P, Bian, A, Gebretsadik, T, Shintani, A, Stein, CM
Format: Article
Language:English
Subjects:
Adult
Age
Age Factors
Atherosclerosis
Cardiovascular disease
Case-Control Studies
Coronary Disease - etiology
Coronary vessels
Female
Humans
Lupus
Lupus Erythematosus, Systemic - complications
Medicine
Middle Aged
Models, Cardiovascular
Risk Assessment
Veins & arteries
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c492t-fe6b3238280a97a3457872e17d5b6a029a50cf6e16f675c7e0f9e95ca05c3b4f3
cites cdi_FETCH-LOGICAL-c492t-fe6b3238280a97a3457872e17d5b6a029a50cf6e16f675c7e0f9e95ca05c3b4f3
container_end_page 1534
container_issue 14
container_start_page 1526
container_title Lupus
container_volume 20
creator Kawai, VK
Solus, JF
Oeser, A
Rho, YH
Raggi, P
Bian, A
Gebretsadik, T
Shintani, A
Stein, CM
description Women with systemic lupus erythematosus (SLE) have increased risk for coronary heart disease (CHD) which is underestimated by the Framingham risk score (FRS). We hypothesized that new risk scores that include inflammation or vascular age in the risk calculation would better identify women with SLE at risk for CHD, particularly in those with subclinical coronary atherosclerosis. We calculated the FRS and Reynolds risk score (RRS) in 121 women with SLE and 65 age-matched female controls; coronary age-modified risk scores (camFRS, camRRS) were calculated using coronary age derived from the coronary artery calcium (CAC) score. Risk scores were compared in SLE and controls, and in SLE patients with and without CAC. Although CAC was present in 21 SLE patients (17%) and four controls (6%) (p = 0.033); the FRS, camFRS, RRS, and camRRS, did not differ significantly among SLE and controls (p > 0.05), but were all significantly higher in SLE patients with CAC compared with those without (p 
doi_str_mv 10.1177/0961203311420317
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3227752</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0961203311420317</sage_id><sourcerecordid>2523414261</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-fe6b3238280a97a3457872e17d5b6a029a50cf6e16f675c7e0f9e95ca05c3b4f3</originalsourceid><addsrcrecordid>eNqFkb1vFDEQxS0EIkegp0IWDdWCP9b2uUFCUSBIETRQUFk-72zOYXe9eLwX3X-PTxcCREJUI_n95nlmHiHPOXvNuTFvmNVcMCk5b2vh5gFZ8daYpr6Lh2R1kJuDfkKeIF4zVhmrH5MTwa3RLRMr8u1T2sFAg89dTDuPYRl8pjnidzpn6GIoMU10TB0MSONEZ18iTAXpTSxbinssMMZAh2VekELely2MviRc8Cl51PsB4dltPSVf359_ObtoLj9_-Hj27rIJrRWl6UFvpJBrsWbeGi9bZdZGADed2mjPhPWKhV4D1702KhhgvQWrgmcqyE3by1Py9ug7L5sRulCny35wc46jz3uXfHR_K1Pcuqu0c1IIY5SoBq9uDXL6sQAWN0YMMAx-grSgs5xztTa2_T_JDG-1VKqSL--R12nJU71DheoerRG6QuwIhZwQM_R3Q3PmDvm6-_nWlhd_LnvX8CvQCjRHAP0V_P70n4Y_Ad1grpU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>906754726</pqid></control><display><type>article</type><title>Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus</title><source>Sage Journals Online</source><creator>Kawai, VK ; Solus, JF ; Oeser, A ; Rho, YH ; Raggi, P ; Bian, A ; Gebretsadik, T ; Shintani, A ; Stein, CM</creator><creatorcontrib>Kawai, VK ; Solus, JF ; Oeser, A ; Rho, YH ; Raggi, P ; Bian, A ; Gebretsadik, T ; Shintani, A ; Stein, CM</creatorcontrib><description>Women with systemic lupus erythematosus (SLE) have increased risk for coronary heart disease (CHD) which is underestimated by the Framingham risk score (FRS). We hypothesized that new risk scores that include inflammation or vascular age in the risk calculation would better identify women with SLE at risk for CHD, particularly in those with subclinical coronary atherosclerosis. We calculated the FRS and Reynolds risk score (RRS) in 121 women with SLE and 65 age-matched female controls; coronary age-modified risk scores (camFRS, camRRS) were calculated using coronary age derived from the coronary artery calcium (CAC) score. Risk scores were compared in SLE and controls, and in SLE patients with and without CAC. Although CAC was present in 21 SLE patients (17%) and four controls (6%) (p = 0.033); the FRS, camFRS, RRS, and camRRS, did not differ significantly among SLE and controls (p &gt; 0.05), but were all significantly higher in SLE patients with CAC compared with those without (p &lt; 0.001 for all). The camFRS (8%, p = 0.016) but not camRRS (5%, p = 0.221) assigned significantly more SLE patients to a category of ≥ 10% risk than conventional FRS (1%) and RRS (2%). The RRS was of limited use but coronary age may improve CHD risk prediction in SLE.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1177/0961203311420317</identifier><identifier>PMID: 21976402</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Age ; Age Factors ; Atherosclerosis ; Cardiovascular disease ; Case-Control Studies ; Coronary Disease - etiology ; Coronary vessels ; Female ; Humans ; Lupus ; Lupus Erythematosus, Systemic - complications ; Medicine ; Middle Aged ; Models, Cardiovascular ; Risk Assessment ; Veins &amp; arteries</subject><ispartof>Lupus, 2011-12, Vol.20 (14), p.1526-1534</ispartof><rights>The Author(s), 2011. Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav</rights><rights>SAGE Publications © Dec 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-fe6b3238280a97a3457872e17d5b6a029a50cf6e16f675c7e0f9e95ca05c3b4f3</citedby><cites>FETCH-LOGICAL-c492t-fe6b3238280a97a3457872e17d5b6a029a50cf6e16f675c7e0f9e95ca05c3b4f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21976402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawai, VK</creatorcontrib><creatorcontrib>Solus, JF</creatorcontrib><creatorcontrib>Oeser, A</creatorcontrib><creatorcontrib>Rho, YH</creatorcontrib><creatorcontrib>Raggi, P</creatorcontrib><creatorcontrib>Bian, A</creatorcontrib><creatorcontrib>Gebretsadik, T</creatorcontrib><creatorcontrib>Shintani, A</creatorcontrib><creatorcontrib>Stein, CM</creatorcontrib><title>Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus</title><title>Lupus</title><addtitle>Lupus</addtitle><description>Women with systemic lupus erythematosus (SLE) have increased risk for coronary heart disease (CHD) which is underestimated by the Framingham risk score (FRS). We hypothesized that new risk scores that include inflammation or vascular age in the risk calculation would better identify women with SLE at risk for CHD, particularly in those with subclinical coronary atherosclerosis. We calculated the FRS and Reynolds risk score (RRS) in 121 women with SLE and 65 age-matched female controls; coronary age-modified risk scores (camFRS, camRRS) were calculated using coronary age derived from the coronary artery calcium (CAC) score. Risk scores were compared in SLE and controls, and in SLE patients with and without CAC. Although CAC was present in 21 SLE patients (17%) and four controls (6%) (p = 0.033); the FRS, camFRS, RRS, and camRRS, did not differ significantly among SLE and controls (p &gt; 0.05), but were all significantly higher in SLE patients with CAC compared with those without (p &lt; 0.001 for all). The camFRS (8%, p = 0.016) but not camRRS (5%, p = 0.221) assigned significantly more SLE patients to a category of ≥ 10% risk than conventional FRS (1%) and RRS (2%). The RRS was of limited use but coronary age may improve CHD risk prediction in SLE.</description><subject>Adult</subject><subject>Age</subject><subject>Age Factors</subject><subject>Atherosclerosis</subject><subject>Cardiovascular disease</subject><subject>Case-Control Studies</subject><subject>Coronary Disease - etiology</subject><subject>Coronary vessels</subject><subject>Female</subject><subject>Humans</subject><subject>Lupus</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Models, Cardiovascular</subject><subject>Risk Assessment</subject><subject>Veins &amp; arteries</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkb1vFDEQxS0EIkegp0IWDdWCP9b2uUFCUSBIETRQUFk-72zOYXe9eLwX3X-PTxcCREJUI_n95nlmHiHPOXvNuTFvmNVcMCk5b2vh5gFZ8daYpr6Lh2R1kJuDfkKeIF4zVhmrH5MTwa3RLRMr8u1T2sFAg89dTDuPYRl8pjnidzpn6GIoMU10TB0MSONEZ18iTAXpTSxbinssMMZAh2VekELely2MviRc8Cl51PsB4dltPSVf359_ObtoLj9_-Hj27rIJrRWl6UFvpJBrsWbeGi9bZdZGADed2mjPhPWKhV4D1702KhhgvQWrgmcqyE3by1Py9ug7L5sRulCny35wc46jz3uXfHR_K1Pcuqu0c1IIY5SoBq9uDXL6sQAWN0YMMAx-grSgs5xztTa2_T_JDG-1VKqSL--R12nJU71DheoerRG6QuwIhZwQM_R3Q3PmDvm6-_nWlhd_LnvX8CvQCjRHAP0V_P70n4Y_Ad1grpU</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Kawai, VK</creator><creator>Solus, JF</creator><creator>Oeser, A</creator><creator>Rho, YH</creator><creator>Raggi, P</creator><creator>Bian, A</creator><creator>Gebretsadik, T</creator><creator>Shintani, A</creator><creator>Stein, CM</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20111201</creationdate><title>Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus</title><author>Kawai, VK ; Solus, JF ; Oeser, A ; Rho, YH ; Raggi, P ; Bian, A ; Gebretsadik, T ; Shintani, A ; Stein, CM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-fe6b3238280a97a3457872e17d5b6a029a50cf6e16f675c7e0f9e95ca05c3b4f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Age</topic><topic>Age Factors</topic><topic>Atherosclerosis</topic><topic>Cardiovascular disease</topic><topic>Case-Control Studies</topic><topic>Coronary Disease - etiology</topic><topic>Coronary vessels</topic><topic>Female</topic><topic>Humans</topic><topic>Lupus</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Models, Cardiovascular</topic><topic>Risk Assessment</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawai, VK</creatorcontrib><creatorcontrib>Solus, JF</creatorcontrib><creatorcontrib>Oeser, A</creatorcontrib><creatorcontrib>Rho, YH</creatorcontrib><creatorcontrib>Raggi, P</creatorcontrib><creatorcontrib>Bian, A</creatorcontrib><creatorcontrib>Gebretsadik, T</creatorcontrib><creatorcontrib>Shintani, A</creatorcontrib><creatorcontrib>Stein, CM</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawai, VK</au><au>Solus, JF</au><au>Oeser, A</au><au>Rho, YH</au><au>Raggi, P</au><au>Bian, A</au><au>Gebretsadik, T</au><au>Shintani, A</au><au>Stein, CM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>20</volume><issue>14</issue><spage>1526</spage><epage>1534</epage><pages>1526-1534</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>Women with systemic lupus erythematosus (SLE) have increased risk for coronary heart disease (CHD) which is underestimated by the Framingham risk score (FRS). We hypothesized that new risk scores that include inflammation or vascular age in the risk calculation would better identify women with SLE at risk for CHD, particularly in those with subclinical coronary atherosclerosis. We calculated the FRS and Reynolds risk score (RRS) in 121 women with SLE and 65 age-matched female controls; coronary age-modified risk scores (camFRS, camRRS) were calculated using coronary age derived from the coronary artery calcium (CAC) score. Risk scores were compared in SLE and controls, and in SLE patients with and without CAC. Although CAC was present in 21 SLE patients (17%) and four controls (6%) (p = 0.033); the FRS, camFRS, RRS, and camRRS, did not differ significantly among SLE and controls (p &gt; 0.05), but were all significantly higher in SLE patients with CAC compared with those without (p &lt; 0.001 for all). The camFRS (8%, p = 0.016) but not camRRS (5%, p = 0.221) assigned significantly more SLE patients to a category of ≥ 10% risk than conventional FRS (1%) and RRS (2%). The RRS was of limited use but coronary age may improve CHD risk prediction in SLE.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>21976402</pmid><doi>10.1177/0961203311420317</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0961-2033
ispartof Lupus, 2011-12, Vol.20 (14), p.1526-1534
issn 0961-2033
1477-0962
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3227752
source Sage Journals Online
subjects Adult
Age
Age Factors
Atherosclerosis
Cardiovascular disease
Case-Control Studies
Coronary Disease - etiology
Coronary vessels
Female
Humans
Lupus
Lupus Erythematosus, Systemic - complications
Medicine
Middle Aged
Models, Cardiovascular
Risk Assessment
Veins & arteries
title Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T15%3A11%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20cardiovascular%20risk%20prediction%20models%20in%20patients%20with%20systemic%20lupus%20erythematosus&rft.jtitle=Lupus&rft.au=Kawai,%20VK&rft.date=2011-12-01&rft.volume=20&rft.issue=14&rft.spage=1526&rft.epage=1534&rft.pages=1526-1534&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1177/0961203311420317&rft_dat=%3Cproquest_pubme%3E2523414261%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c492t-fe6b3238280a97a3457872e17d5b6a029a50cf6e16f675c7e0f9e95ca05c3b4f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=906754726&rft_id=info:pmid/21976402&rft_sage_id=10.1177_0961203311420317&rfr_iscdi=true